Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Victoria C De Leon

2 papers in the library · publishing 2022-2024

Papers

Nitrous Oxide Alters Functional Connectivity in Medial Limbic Structures in Treatment-Resistant Major Depression.

medRxiv : the preprint server for health sciences August 17, 2024 Charles R Conway, Ben Julian A Palanca, Thomas Zeffiro et al. preprint

Nitrous oxide (N2O) reduces functional connectivity in mood-related brain networks in people with treatment-resistant major depression (TRD) but increases connectivity in healthy controls. In a crossover trial, 14 TRD patients and 16 healthy controls received one-hour inhalations of 50% N2O or placebo. Resting-state fMRI scans before, 2 hours, and 24 hours after inhalation showed that N2O progressively decreased connectivity in TRD patients across five brain networks (salience, default mode, reward, cingulo-opercular, and the dorsal nexus), while increasing connectivity in controls. The findings suggest N2O's antidepressant effects involve specific alterations in depressed brains.

Nitrous Oxide: an emerging novel treatment for treatment-resistant depression.

Journal of the Neurological Sciences March 15, 2022 Darin F Quach, Victoria C De Leon, Charles R Conway

About 20-25% of people with major depressive disorder do not respond to standard antidepressants, prompting the search for new treatments. Ketamine, which acts on the NMDA receptor, has drawn substantial research interest. Nitrous oxide, used for over a century as an anesthetic and analgesic, is now being studied for treatment-resistant depression. This review covers nitrous oxide's use as a psychiatric intervention, its current applications in psychiatry, proposed mechanisms of action, and future research directions, including knowledge gaps and other potential psychiatric uses.